REVOLUTION Medicines Inc
RVMD·Stocks·Pharmaceuticals Other·United States·Nasdaq·USD
Price
$161.06
Today
+1.1%
YTD
+102.4%
About
Operating within the US, Revolution Medicines is a clinical-stage precision oncology company. It works to develop therapies to inhibit targets primarily within the mTOR and RAS signalling pathways. Founded in 2014, the company has headquarters in Redwood City, California. It is listed on the NASDAQ GS stock market with the ticker RVMD. Make your portfolio more diverse by adding RVMD stock to your holdings.
Price chart
Closing price history for RVMD (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)-17.72
P/S (TTM)175.39
P/B (TTM)14.52
Market cap$34.87B
Cap tierLarge-cap
Industry avg P/E-3.15
Profitability
Gross margin90.31%
EBIT margin-852.98%
Net margin-206.25%
ROE-93.56%
ROA-57.07%
Earnings & Revenue
Revenue (TTM)$197.56M
Revenue growth (1Y)-100.0%
EPS (TTM)-$9.10
Free cash flow$-1.44B
Total debt$1.21B
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.14
Employees883
Next earnings24 Feb '27
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.